These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17269888)

  • 1. Evaluation of the ability of canarypox-vectored equine influenza virus vaccines to induce humoral immune responses against canine influenza viruses in dogs.
    Karaca K; Dubovi EJ; Siger L; Robles A; Audonnet JC; Jiansheng Y; Nordgren R; Minke JM
    Am J Vet Res; 2007 Feb; 68(2):208-12. PubMed ID: 17269888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
    Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine.
    Minke JM; Toulemonde CE; Dinic S; Cozette V; Cullinane A; Audonnet JC
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S76-80. PubMed ID: 17559865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
    Paillot R; Kydd JH; Sindle T; Hannant D; Edlund Toulemonde C; Audonnet JC; Minke JM; Daly JM
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):225-33. PubMed ID: 16621023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cell-mediated immune responses of old horses following recombinant canarypox virus vaccination and subsequent challenge infection.
    Adams AA; Sturgill TL; Breathnach CC; Chambers TM; Siger L; Minke JM; Horohov DW
    Vet Immunol Immunopathol; 2011 Feb; 139(2-4):128-40. PubMed ID: 21035197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy of a canine influenza virus (H3N8) vaccine in dogs following experimental challenge.
    Deshpande MS; Jirjis FF; Tubbs AL; Jayappa H; Sweeney D; Spencer SJ; Lakshmanan N; Wasmoen TL
    Vet Ther; 2009; 10(3):103-12. PubMed ID: 20037964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of infectivity of a canine lineage H3N8 influenza A virus in ponies and in primary equine respiratory epithelial cells.
    Quintana AM; Hussey SB; Burr EC; Pecoraro HL; Annis KM; Rao S; Landolt GA
    Am J Vet Res; 2011 Aug; 72(8):1071-8. PubMed ID: 21801065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses.
    Rodriguez L; Nogales A; Murcia PR; Parrish CR; Martínez-Sobrido L
    Vaccine; 2017 Aug; 35(34):4374-4381. PubMed ID: 28709557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
    Van de Walle GR; May MA; Peters ST; Metzger SM; Rosas CT; Osterrieder N
    Vaccine; 2010 Jan; 28(4):1048-55. PubMed ID: 19897066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental reproduction of canine influenza virus H3N8 infection in young puppies.
    Deshpande M; Abdelmagid O; Tubbs A; Jayappa H; Wasmoen T
    Vet Ther; 2009; 10(1-2):29-39. PubMed ID: 19742446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
    Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the response to an accelerated immunisation schedule using a canarypox-vectored equine influenza vaccine, shortened interdose intervals and vaccination of young foals.
    Minke JM; El-Hage CM; Tazawa P; Homer D; Lemaitre L; Cozette V; Gilkerson JR; Kirkland PD
    Aust Vet J; 2011 Jul; 89 Suppl 1():137-9. PubMed ID: 21711312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine.
    Nogales A; Rodriguez L; Chauché C; Huang K; Reilly EC; Topham DJ; Murcia PR; Parrish CR; Martínez-Sobrido L
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New assays to measure equine influenza virus-specific Type 1 immunity in horses.
    Paillot R; Kydd JH; MacRae S; Minke JM; Hannant D; Daly JM
    Vaccine; 2007 Oct; 25(42):7385-98. PubMed ID: 17881098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interspecies transmission of equine influenza virus (H3N8) to dogs by close contact with experimentally infected horses.
    Yamanaka T; Nemoto M; Tsujimura K; Kondo T; Matsumura T
    Vet Microbiol; 2009 Nov; 139(3-4):351-5. PubMed ID: 19596528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological evidence of H3N8 canine influenza-like virus circulation in USA dogs prior to 2004.
    Anderson TC; Bromfield CR; Crawford PC; Dodds WJ; Gibbs EP; Hernandez JA
    Vet J; 2012 Mar; 191(3):312-6. PubMed ID: 22178358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a vectored equine herpesvirus type 1 (EHV-1) vaccine expressing H3 haemagglutinin in the protection of dogs against canine influenza.
    Rosas C; Van de Walle GR; Metzger SM; Hoelzer K; Dubovi EJ; Kim SG; Parrish CR; Osterrieder N
    Vaccine; 2008 May; 26(19):2335-43. PubMed ID: 18407383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination.
    Soboll G; Hussey SB; Minke JM; Landolt GA; Hunter JS; Jagannatha S; Lunn DP
    Vet Immunol Immunopathol; 2010 May; 135(1-2):100-107. PubMed ID: 20018384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.